Risk of Second Primary Malignancies in Lung Cancer Survivors – The Influence of Different Treatments

被引:0
作者
Vincent Yi-Fong Su
Chia-Jen Liu
Yuh-Min Chen
Teh-Ying Chou
Tzeng-Ji Chen
Sang-Hue Yen
Tzeon-Jye Chiou
Jin-Hwang Liu
Yu-Wen Hu
机构
[1] Taipei Veterans General Hospital,Department of Critical Care Medicine
[2] National Yang-Ming University,Institute of Clinical Medicine
[3] National Yang-Ming University,Faculty of Medicine
[4] Taipei Veterans General Hospital,Division of Hematology and Oncology, Department of Medicine
[5] National Yang-Ming University,Institute of Public Health
[6] Taipei Medical University,Taipei Cancer Center
[7] Taipei Veterans General Hospital,Molecular Pathology, Department of Pathology and Laboratory Medicine
[8] Taipei Veterans General Hospital,Department of Family Medicine
[9] Taipei Veterans General Hospital,Cancer Center
[10] National Yang-Ming University,Department of Biomedical Imaging and Radiological Sciences, School of Medicine
[11] Taipei Veterans General Hospital,Division of Transfusion Medicine, Department of Medicine
[12] National Defense Medical Center,undefined
来源
Targeted Oncology | 2017年 / 12卷
关键词
Lung Cancer; Chronic Obstructive Pulmonary Disease; Thyroid Cancer; Lung Cancer Patient; Epidermal Growth Factor Receptor Mutation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:219 / 227
页数:8
相关论文
共 79 条
[71]  
Goldberg Z(undefined)undefined undefined undefined undefined-undefined
[72]  
Sigurdson AJ(undefined)undefined undefined undefined undefined-undefined
[73]  
Jones IM(undefined)undefined undefined undefined undefined-undefined
[74]  
Wang BY(undefined)undefined undefined undefined undefined-undefined
[75]  
Huang JY(undefined)undefined undefined undefined undefined-undefined
[76]  
Cheng CY(undefined)undefined undefined undefined undefined-undefined
[77]  
Lin CH(undefined)undefined undefined undefined undefined-undefined
[78]  
Ko J(undefined)undefined undefined undefined undefined-undefined
[79]  
Liaw YP(undefined)undefined undefined undefined undefined-undefined